J 2012

Dementia Diagnosis and Treatment in Czech Neurological and Psychiatric Practices

SHEARDOVÁ, K., J. HORT, Irena REKTOROVÁ, R. RUSINA, V. LÍNEK et. al.

Basic information

Original name

Dementia Diagnosis and Treatment in Czech Neurological and Psychiatric Practices

Name in Czech

Diagnostika a léčba demence českými neurology a psychiatry

Authors

SHEARDOVÁ, K. (203 Czech Republic), J. HORT (203 Czech Republic), Irena REKTOROVÁ (203 Czech Republic, guarantor, belonging to the institution), R. RUSINA (203 Czech Republic), V. LÍNEK (203 Czech Republic) and A. BARTOŠ (203 Czech Republic)

Edition

Česká a slovenská neurologie a neurochirurgie, Praha, Česká lékařská společnost J.E.Purkyně, 2012, 1210-7859

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 0.372

RIV identification code

RIV/00216224:14110/12:00068877

Organization unit

Faculty of Medicine

UT WoS

000303294000011

Keywords in English

Alzheimer's disease; dementia; management; cholinesterase inhibitors; Czech Republic

Tags

International impact, Reviewed
Změněno: 22/7/2013 15:02, Ing. Mgr. Věra Pospíšilíková

Abstract

V originále

The aim of the study: The aim of this study was to obtain comprehensive information about standard practice in management of dementia among specialists responsible for the care of patients with cognitive deterioration in the Czech Republic. Methods: The data were collected by the means of structured questionnaires completed by neurologists, psychiatrists and geriatricians during seminars focused on cognitive topics. Results: 152 specialists were participating in the study. The respondents saw the mean of 27 patients with cognitive deficit monthly, 33% of whom suffer from Alzheimer disease. Neurologists diagnosed equal proportions of patients with mild cognitive impairment, and with mild to moderate stages of dementia; psychiatrists and geriatricians mostly diagnose patients at the moderate stage of the disease. Nearly all of the neurologists and half of the psychiatrists examined their patients by MRI or CT prior to starting therapy. SPECT was mainly used by neurologists (42%). The majority of patients took cholinesterase inhibitor (ChEI) for 2-3 years. Half of the specialists occasionally used dual therapy with ChEI and memantine. Nootropics were administered more frequently by psychiatrists. All the respondents prescribed an Selective Serotonin Reuptake Inhibitors (SSRI) for the therapy of coinciding depression. Conclusion: Dementia was managed by the majority of specialists according to the EFNS guidelines. The early stages of the disease were mostly handled by neurologists, who also tend to employ more sophisticated diagnostic tools in differential diagnosis of dementia.